New drugs and gene therapies designed to treat cancer, rare diseases, etc. are justifiably commanding high prices. However, if they don’t work, payments shouldn’t be required.
from Forbes Real Time https://www.forbes.com/sites/johnlamattina/2018/05/02/for-expensive-new-drugs-biopharma-should-make-money-back-guarantees-mandatory/
via IFTTT
No comments:
Post a Comment